Clause 4

after the definition of “advertisement”, insert —“ “approved institution” has the meaning given by section 2 of the Misuse of Drugs Act 1973;”;

replace the definition of “Chief Executive” with —“ “Chief Executive” has the meaning given by section 2 of the Health Sciences Authority Act 2001;“child” means any person who is below 16 years of age;”;

after the definition of “cigarette”, insert —“ “community rehabilitation centre” has the meaning given by section 2 of the Misuse of Drugs Act 1973;”;

replace the definition of “imitation tobacco product” with —“ “imitation tobacco product” means anything mentioned in section 16A(1)(a), but excludes any vaporiser;“inmate” means a person who is detained in an approved institution or a community rehabilitation centre pursuant to an order made under section 19T;”;

after the definition of “newspaper”, insert —“ “nicotine analogue” means a substance —

the chemical structure of which is similar to the chemical structure of nicotine; or

the consumption or use of which has neurological effects that are similar in nature to the neurological effects associated with the consumption or use of nicotine; Illustrations Nicotine salts. Nicotine derivatives.”;

after the definition of “premises”, insert —“ “psychoactive effect” means the stimulation or depression, whether directly or indirectly, of an individual’s central nervous system, affecting the individual’s mental functioning or emotional state;”;

after the definition of “retail outlet”, insert —“ “Review Committee” has the meaning given by section 2 of the Misuse of Drugs Act 1973;“section 14 tobacco product” means a tobacco product that is, or falls within a class of tobacco products, described in section 14(1);“section 15 tobacco product” means a tobacco product that is, or falls within a class of tobacco products, described in section 15(1)(a);”;

after the definition of “smoking”, insert —“ “specified psychoactive substance” means a substance or product specified in the Schedule or falling within a class of substances or products specified in the Schedule, being a substance or product —

that has the capacity to have a psychoactive effect on an individual if the individual smokes, inhales or otherwise consumes, the substance or product; and

that is abused or is likely to be abused by using a Part 3A product as defined in section 19A(1);”;

in the definition of “tobacco product”, in paragraph (c), delete “or” at the end;

in the definition of “tobacco product”, in paragraph (d), replace the comma at the end with “; or”;

in the definition of “tobacco product”, after paragraph (d), insert —“(e)any article or thing that comprises 2 or more components, at least one of which is or contains any form of tobacco, a tobacco derivative, a tobacco substitute or a mixture mentioned in paragraph (d),”;

in the definition of “tobacco substitute”, after “nicotine”, insert “or a nicotine analogue”;

after the definition of “use”, insert —“ “vaporiser” means any device or article that is used, intended to be used or described to be suitable for use for the purpose of vaporising any liquid or substance to produce any emission (including any aerosol) for oral inhalation by a user of the device or article, but does not include —

any section 15 tobacco product; or

a therapeutic product registered under the Health Products Act 2007;“vulnerable person” means any person who suffers from an impairment of, or a disturbance in the functioning of, the mind or brain resulting from any disability or disorder of the mind or brain which impairs the ability to make a proper judgment in relation to the commission of any offence under this Act;”;

in the definition of “writing”, replace the full‑stop at the end with a semi‑colon; and

after the definition of “writing”, insert —“ “young person” means any person who is below 21 years of age.”.